TRPM4 and cancer: In a parallel study, we discovered a unified mechanism of activity for both Acetalax and bisacodyl in cancer cells that likely involves the trapping of TRPM4 followed by its rapid degradation, cell membrane disruption, increased cellular volume, and mitochondrial defects with ATP depletion (12).